Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13016 entries
Sorted by: Best Match Show Resources per page
Hamming Distance as a Concept in DNA Molecular Recognition.

ACS omega

Mohammadi-Kambs M, Hölz K, Somoza MM, Ott A.
PMID: 28474009
ACS Omega. 2017 Apr 30;2(4):1302-1308. doi: 10.1021/acsomega.7b00053. Epub 2017 Apr 05.

DNA microarrays constitute an in vitro example system of a highly crowded molecular recognition environment. Although they are widely applied in many biological applications, some of the basic mechanisms of the hybridization processes of DNA remain poorly understood. On...

Cite
Mohammadi-Kambs M, Hölz K, Somoza MM, et al. Hamming Distance as a Concept in DNA Molecular Recognition. ACS Omega. 2017;2(4):1302-1308doi: 10.1021/acsomega.7b00053.
Mohammadi-Kambs, M., Hölz, K., Somoza, M. M., & Ott, A. (2017). Hamming Distance as a Concept in DNA Molecular Recognition. ACS omega, 2(4), 1302-1308. https://doi.org/10.1021/acsomega.7b00053
Mohammadi-Kambs, Mina, et al. "Hamming Distance as a Concept in DNA Molecular Recognition." ACS omega vol. 2,4 (2017): 1302-1308. doi: https://doi.org/10.1021/acsomega.7b00053
Mohammadi-Kambs M, Hölz K, Somoza MM, Ott A. Hamming Distance as a Concept in DNA Molecular Recognition. ACS Omega. 2017 Apr 30;2(4):1302-1308. doi: 10.1021/acsomega.7b00053. Epub 2017 Apr 05. PMID: 28474009; PMCID: PMC5410656.
Copy Download .nbib Format: NLM
Development of β-Hairpin Peptides for the Measurement of SCF-Family E3 Ligase Activity in Vitro via Ornithine Ubiquitination.

ACS omega

Houston KM, Melvin AT, Woss GS, Fayer EL, Waters ML, Allbritton NL.
PMID: 28393136
ACS Omega. 2017 Mar 31;2(3):1198-1206. doi: 10.1021/acsomega.7b00109. Epub 2017 Mar 29.

Regulation of the ubiquitin-proteasome system (UPS) to treat select types of cancer has become a popular area of drug discovery research. The FDA approval of proteasome inhibitors Bortezomib and Carfilzomib in the treatment of multiple myeloma has led to...

Cite
Houston KM, Melvin AT, Woss GS, et al. Development of β-Hairpin Peptides for the Measurement of SCF-Family E3 Ligase Activity in Vitro via Ornithine Ubiquitination. ACS Omega. 2017;2(3):1198-1206doi: 10.1021/acsomega.7b00109.
Houston, K. M., Melvin, A. T., Woss, G. S., Fayer, E. L., Waters, M. L., & Allbritton, N. L. (2017). Development of β-Hairpin Peptides for the Measurement of SCF-Family E3 Ligase Activity in Vitro via Ornithine Ubiquitination. ACS omega, 2(3), 1198-1206. https://doi.org/10.1021/acsomega.7b00109
Houston, Kaiulani M, et al. "Development of β-Hairpin Peptides for the Measurement of SCF-Family E3 Ligase Activity in Vitro via Ornithine Ubiquitination." ACS omega vol. 2,3 (2017): 1198-1206. doi: https://doi.org/10.1021/acsomega.7b00109
Houston KM, Melvin AT, Woss GS, Fayer EL, Waters ML, Allbritton NL. Development of β-Hairpin Peptides for the Measurement of SCF-Family E3 Ligase Activity in Vitro via Ornithine Ubiquitination. ACS Omega. 2017 Mar 31;2(3):1198-1206. doi: 10.1021/acsomega.7b00109. Epub 2017 Mar 29. PMID: 28393136; PMCID: PMC5377275.
Copy Download .nbib Format: NLM
Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini.

ACS omega

Piehl DW, Blancas-Mejía LM, Wall JS, Kennel SJ, Ramirez-Alvarado M, Rienstra CM.
PMID: 28261692
ACS Omega. 2017 Feb 28;2(2):712-720. doi: 10.1021/acsomega.6b00494. Epub 2017 Feb 27.

Light-chain (AL)-associated amyloidosis is a systemic disorder involving the formation and deposition of immunoglobulin AL fibrils in various bodily organs. One severe instance of AL disease is exhibited by the patient-derived variable domain (V

Cite
Piehl DW, Blancas-Mejía LM, Wall JS, et al. Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini. ACS Omega. 2017;2(2):712-720doi: 10.1021/acsomega.6b00494.
Piehl, D. W., Blancas-Mejía, L. M., Wall, J. S., Kennel, S. J., Ramirez-Alvarado, M., & Rienstra, C. M. (2017). Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini. ACS omega, 2(2), 712-720. https://doi.org/10.1021/acsomega.6b00494
Piehl, Dennis W, et al. "Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini." ACS omega vol. 2,2 (2017): 712-720. doi: https://doi.org/10.1021/acsomega.6b00494
Piehl DW, Blancas-Mejía LM, Wall JS, Kennel SJ, Ramirez-Alvarado M, Rienstra CM. Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini. ACS Omega. 2017 Feb 28;2(2):712-720. doi: 10.1021/acsomega.6b00494. Epub 2017 Feb 27. PMID: 28261692; PMCID: PMC5331457.
Copy Download .nbib Format: NLM
Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches.

ACS omega

Rombouts FJR, Alexander R, Cleiren E, De Groot A, Carpentier M, Dijkmans J, Fierens K, Masure S, Moechars D, Palomino-Schätzlein M, Pineda-Lucena A, Trabanco AA, Van Glabbeek D, Vos A, Tresadern G.
PMID: 28626832
ACS Omega. 2017 Feb 28;2(2):685-697. doi: 10.1021/acsomega.6b00482. Epub 2017 Feb 24.

An approach to identify β-secretase 1 (BACE1) fragment binders that do not interact with the catalytic aspartate dyad is presented. A ThermoFluor (thermal shift) and a fluorescence resonance energy transfer enzymatic screen on the soluble domain of BACE1, together...

Cite
Rombouts FJR, Alexander R, Cleiren E, et al. Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches. ACS Omega. 2017;2(2):685-697doi: 10.1021/acsomega.6b00482.
Rombouts, F. J. R., Alexander, R., Cleiren, E., De Groot, A., Carpentier, M., Dijkmans, J., Fierens, K., Masure, S., Moechars, D., Palomino-Schätzlein, M., Pineda-Lucena, A., Trabanco, A. A., Van Glabbeek, D., Vos, A., & Tresadern, G. (2017). Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches. ACS omega, 2(2), 685-697. https://doi.org/10.1021/acsomega.6b00482
Rombouts, Frederik J R, et al. "Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches." ACS omega vol. 2,2 (2017): 685-697. doi: https://doi.org/10.1021/acsomega.6b00482
Rombouts FJR, Alexander R, Cleiren E, De Groot A, Carpentier M, Dijkmans J, Fierens K, Masure S, Moechars D, Palomino-Schätzlein M, Pineda-Lucena A, Trabanco AA, Van Glabbeek D, Vos A, Tresadern G. Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches. ACS Omega. 2017 Feb 28;2(2):685-697. doi: 10.1021/acsomega.6b00482. Epub 2017 Feb 24. PMID: 28626832; PMCID: PMC5472370.
Copy Download .nbib Format: NLM
Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia.

ACS omega

Jarusiewicz JA, Jeon JY, Connelly MC, Chen Y, Yang L, Baker SD, Guy RK.
PMID: 28580438
ACS Omega. 2017 May 31;2(5):1985-2009. doi: 10.1021/acsomega.7b00144. Epub 2017 May 10.

Profiling of the kinase-binding capabilities of an aminopyrimidine analogue detected in a cellular screen of the St. Jude small-molecule collection led to the identification of a novel series of FMS-like tyrosine kinase 3 (FLT3) inhibitors. Structure-activity relationship studies led...

Cite
Jarusiewicz JA, Jeon JY, Connelly MC, et al. Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia. ACS Omega. 2017;2(5):1985-2009doi: 10.1021/acsomega.7b00144.
Jarusiewicz, J. A., Jeon, J. Y., Connelly, M. C., Chen, Y., Yang, L., Baker, S. D., & Guy, R. K. (2017). Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia. ACS omega, 2(5), 1985-2009. https://doi.org/10.1021/acsomega.7b00144
Jarusiewicz, Jamie A, et al. "Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia." ACS omega vol. 2,5 (2017): 1985-2009. doi: https://doi.org/10.1021/acsomega.7b00144
Jarusiewicz JA, Jeon JY, Connelly MC, Chen Y, Yang L, Baker SD, Guy RK. Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia. ACS Omega. 2017 May 31;2(5):1985-2009. doi: 10.1021/acsomega.7b00144. Epub 2017 May 10. PMID: 28580438; PMCID: PMC5452050.
Copy Download .nbib Format: NLM
Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids.

ACS omega

Ramos-Cabrer P, Fay F, Sanchez-Gaytan BL, Tang J, Castillo J, Fayad ZA, Mulder WJ.
PMID: 27713933
ACS Omega. 2016 Sep 30;1(3):470-475. doi: 10.1021/acsomega.6b00108. Epub 2016 Sep 26.

High-density lipoprotein (HDL) nanoparticles doped with gadolinium lipids can be used as magnetic resonance imaging diagnostic agents for atherosclerosis. In this study, HDL nanoparticles with different molar fractions of gadolinium lipids (0 <

Cite
Ramos-Cabrer P, Fay F, Sanchez-Gaytan BL, et al. Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids. ACS Omega. 2016;1(3):470-475doi: 10.1021/acsomega.6b00108.
Ramos-Cabrer, P., Fay, F., Sanchez-Gaytan, B. L., Tang, J., Castillo, J., Fayad, Z. A., & Mulder, W. J. (2016). Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids. ACS omega, 1(3), 470-475. https://doi.org/10.1021/acsomega.6b00108
Ramos-Cabrer, Pedro, et al. "Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids." ACS omega vol. 1,3 (2016): 470-475. doi: https://doi.org/10.1021/acsomega.6b00108
Ramos-Cabrer P, Fay F, Sanchez-Gaytan BL, Tang J, Castillo J, Fayad ZA, Mulder WJ. Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids. ACS Omega. 2016 Sep 30;1(3):470-475. doi: 10.1021/acsomega.6b00108. Epub 2016 Sep 26. PMID: 27713933; PMCID: PMC5046173.
Copy Download .nbib Format: NLM
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit .

ACS omega

Linciano P, Dawson A, Pöhner I, Costa DM, Sá MS, Cordeiro-da-Silva A, Luciani R, Gul S, Witt G, Ellinger B, Kuzikov M, Gribbon P, Reinshagen J, Wolf M, Behrens B, Hannaert V, Michels PAM, Nerini E, Pozzi C, di Pisa F, Landi G, Santarem N, Ferrari S, Saxena P, Lazzari S, Cannazza G, Freitas-Junior LH, Moraes CB, Pascoalino BS, Alcântara LM, Bertolacini CP, Fontana V, Wittig U, Müller W, Wade RC, Hunter WN, Mangani S, Costantino L, Costi MP.
PMID: 28983525
ACS Omega. 2017 Sep 30;2(9):5666-5683. doi: 10.1021/acsomega.7b00473. Epub 2017 Sep 11.

Pteridine reductase-1 (PTR1) is a promising drug target for the treatment of trypanosomiasis. We investigated the potential of a previously identified class of thiadiazole inhibitors of

Cite
Linciano P, Dawson A, Pöhner I, et al. Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit . ACS Omega. 2017;2(9):5666-5683doi: 10.1021/acsomega.7b00473.
Linciano, P., Dawson, A., Pöhner, I., Costa, D. M., Sá, M. S., Cordeiro-da-Silva, A., Luciani, R., Gul, S., Witt, G., Ellinger, B., Kuzikov, M., Gribbon, P., Reinshagen, J., Wolf, M., Behrens, B., Hannaert, V., Michels, P. A. M., Nerini, E., Pozzi, C., di Pisa, F., Landi, G., Santarem, N., Ferrari, S., Saxena, P., Lazzari, S., Cannazza, G., Freitas-Junior, L. H., Moraes, C. B., Pascoalino, B. S., Alcântara, L. M., Bertolacini, C. P., Fontana, V., Wittig, U., Müller, W., Wade, R. C., Hunter, W. N., Mangani, S., Costantino, L., & Costi, M. P. (2017). Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit . ACS omega, 2(9), 5666-5683. https://doi.org/10.1021/acsomega.7b00473
Linciano, Pasquale, et al. "Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit ." ACS omega vol. 2,9 (2017): 5666-5683. doi: https://doi.org/10.1021/acsomega.7b00473
Linciano P, Dawson A, Pöhner I, Costa DM, Sá MS, Cordeiro-da-Silva A, Luciani R, Gul S, Witt G, Ellinger B, Kuzikov M, Gribbon P, Reinshagen J, Wolf M, Behrens B, Hannaert V, Michels PAM, Nerini E, Pozzi C, di Pisa F, Landi G, Santarem N, Ferrari S, Saxena P, Lazzari S, Cannazza G, Freitas-Junior LH, Moraes CB, Pascoalino BS, Alcântara LM, Bertolacini CP, Fontana V, Wittig U, Müller W, Wade RC, Hunter WN, Mangani S, Costantino L, Costi MP. Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit . ACS Omega. 2017 Sep 30;2(9):5666-5683. doi: 10.1021/acsomega.7b00473. Epub 2017 Sep 11. PMID: 28983525; PMCID: PMC5623949.
Copy Download .nbib Format: NLM
Quantification of Oxygen Nanobubbles in Particulate Matters and Potential Applications in Remediation of Anaerobic Environment.

ACS omega

Wang L, Miao X, Ali J, Lyu T, Pan G.
PMID: 30320247
ACS Omega. 2018 Sep 30;3(9):10624-10630. doi: 10.1021/acsomega.8b00784. Epub 2018 Sep 05.

Interfacial nanobubbles can exist on various hydrophobic and hydrophilic material interfaces. There are diverse applications for oxygen nanobubbles, which are closely related to their content and long-term stability. However, it remains challenging to determine the amount of nanobubbles loaded...

Cite
Wang L, Miao X, Ali J, et al. Quantification of Oxygen Nanobubbles in Particulate Matters and Potential Applications in Remediation of Anaerobic Environment. ACS Omega. 2018;3(9):10624-10630doi: 10.1021/acsomega.8b00784.
Wang, L., Miao, X., Ali, J., Lyu, T., & Pan, G. (2018). Quantification of Oxygen Nanobubbles in Particulate Matters and Potential Applications in Remediation of Anaerobic Environment. ACS omega, 3(9), 10624-10630. https://doi.org/10.1021/acsomega.8b00784
Wang, Lei, et al. "Quantification of Oxygen Nanobubbles in Particulate Matters and Potential Applications in Remediation of Anaerobic Environment." ACS omega vol. 3,9 (2018): 10624-10630. doi: https://doi.org/10.1021/acsomega.8b00784
Wang L, Miao X, Ali J, Lyu T, Pan G. Quantification of Oxygen Nanobubbles in Particulate Matters and Potential Applications in Remediation of Anaerobic Environment. ACS Omega. 2018 Sep 30;3(9):10624-10630. doi: 10.1021/acsomega.8b00784. Epub 2018 Sep 05. PMID: 30320247; PMCID: PMC6173480.
Copy Download .nbib Format: NLM
C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors.

ACS omega

Ganeshapillai D, Woo LWL, Thomas MP, Purohit A, Potter BVL.
PMID: 30320251
ACS Omega. 2018 Sep 30;3(9):10748-10772. doi: 10.1021/acsomega.8b01383. Epub 2018 Sep 06.

Synthetic routes to potent bicyclic nonsteroidal sulfamate-based active-site-directed inhibitors of the enzyme steroid sulfatase (STS), an emerging target in the treatment of postmenopausal hormone-dependent diseases, including breast cancer, are described. Sulfamate analogs

Cite
Ganeshapillai D, Woo LWL, Thomas MP, et al. C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors. ACS Omega. 2018;3(9):10748-10772doi: 10.1021/acsomega.8b01383.
Ganeshapillai, D., Woo, L. W. L., Thomas, M. P., Purohit, A., & Potter, B. V. L. (2018). C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors. ACS omega, 3(9), 10748-10772. https://doi.org/10.1021/acsomega.8b01383
Ganeshapillai, Dharshini, et al. "C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors." ACS omega vol. 3,9 (2018): 10748-10772. doi: https://doi.org/10.1021/acsomega.8b01383
Ganeshapillai D, Woo LWL, Thomas MP, Purohit A, Potter BVL. C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors. ACS Omega. 2018 Sep 30;3(9):10748-10772. doi: 10.1021/acsomega.8b01383. Epub 2018 Sep 06. PMID: 30320251; PMCID: PMC6173509.
Copy Download .nbib Format: NLM
Synthesis and Phase Transformation Studies of Dysprosium-Doped Bi.

ACS omega

Naqvi FK, Faraz M, Beg S, Khare N.
PMID: 30320259
ACS Omega. 2018 Sep 30;3(9):11300-11306. doi: 10.1021/acsomega.8b01012. Epub 2018 Sep 17.

Recently, Bi

Cite
Naqvi FK, Faraz M, Beg S, et al. Synthesis and Phase Transformation Studies of Dysprosium-Doped Bi. ACS Omega. 2018;3(9):11300-11306doi: 10.1021/acsomega.8b01012.
Naqvi, F. K., Faraz, M., Beg, S., & Khare, N. (2018). Synthesis and Phase Transformation Studies of Dysprosium-Doped Bi. ACS omega, 3(9), 11300-11306. https://doi.org/10.1021/acsomega.8b01012
Naqvi, Faria K, et al. "Synthesis and Phase Transformation Studies of Dysprosium-Doped Bi." ACS omega vol. 3,9 (2018): 11300-11306. doi: https://doi.org/10.1021/acsomega.8b01012
Naqvi FK, Faraz M, Beg S, Khare N. Synthesis and Phase Transformation Studies of Dysprosium-Doped Bi. ACS Omega. 2018 Sep 30;3(9):11300-11306. doi: 10.1021/acsomega.8b01012. Epub 2018 Sep 17. PMID: 30320259; PMCID: PMC6175493.
Copy Download .nbib Format: NLM
Biological Evaluation and Docking Studies of Synthetic Oleanane-type Triterpenoids.

ACS omega

Ortega-Muñoz M, Rodríguez-Serrano F, De Los Reyes-Berbel E, Mut-Salud N, Hernández-Mateo F, Rodríguez-López A, Garrido JM, López-Jaramillo FJ, Santoyo-González F.
PMID: 30320262
ACS Omega. 2018 Sep 30;3(9):11455-11468. doi: 10.1021/acsomega.8b01034. Epub 2018 Sep 20.

Saponins are potential wide-spectrum antitumor drugs, and copper(I) catalyzed azide-alkyne 1,3-dipolar cycloaddition is a suitable approach to synthesizing saponin-like compounds by regioselective glycosylation of the C2/C3 hydroxyl and C28 carboxylic groups of triterpene aglycones maslinic acid (MA) and oleanolic...

Cite
Ortega-Muñoz M, Rodríguez-Serrano F, De Los Reyes-Berbel E, et al. Biological Evaluation and Docking Studies of Synthetic Oleanane-type Triterpenoids. ACS Omega. 2018;3(9):11455-11468doi: 10.1021/acsomega.8b01034.
Ortega-Muñoz, M., Rodríguez-Serrano, F., De Los Reyes-Berbel, E., Mut-Salud, N., Hernández-Mateo, F., Rodríguez-López, A., Garrido, J. M., López-Jaramillo, F. J., & Santoyo-González, F. (2018). Biological Evaluation and Docking Studies of Synthetic Oleanane-type Triterpenoids. ACS omega, 3(9), 11455-11468. https://doi.org/10.1021/acsomega.8b01034
Ortega-Muñoz, Mariano, et al. "Biological Evaluation and Docking Studies of Synthetic Oleanane-type Triterpenoids." ACS omega vol. 3,9 (2018): 11455-11468. doi: https://doi.org/10.1021/acsomega.8b01034
Ortega-Muñoz M, Rodríguez-Serrano F, De Los Reyes-Berbel E, Mut-Salud N, Hernández-Mateo F, Rodríguez-López A, Garrido JM, López-Jaramillo FJ, Santoyo-González F. Biological Evaluation and Docking Studies of Synthetic Oleanane-type Triterpenoids. ACS Omega. 2018 Sep 30;3(9):11455-11468. doi: 10.1021/acsomega.8b01034. Epub 2018 Sep 20. PMID: 30320262; PMCID: PMC6173505.
Copy Download .nbib Format: NLM
1.

ACS omega

Kumar S, Saha ST, Gu L, Palma G, Perumal S, Singh-Pillay A, Singh P, Anand A, Kaur M, Kumar V.
PMID: 30320289
ACS Omega. 2018 Sep 30;3(9):12106-12113. doi: 10.1021/acsomega.8b01513. Epub 2018 Sep 27.

1

Cite
Kumar S, Saha ST, Gu L, et al. 1. ACS Omega. 2018;3(9):12106-12113doi: 10.1021/acsomega.8b01513.
Kumar, S., Saha, S. T., Gu, L., Palma, G., Perumal, S., Singh-Pillay, A., Singh, P., Anand, A., Kaur, M., & Kumar, V. (2018). 1. ACS omega, 3(9), 12106-12113. https://doi.org/10.1021/acsomega.8b01513
Kumar, Sumit, et al. "1." ACS omega vol. 3,9 (2018): 12106-12113. doi: https://doi.org/10.1021/acsomega.8b01513
Kumar S, Saha ST, Gu L, Palma G, Perumal S, Singh-Pillay A, Singh P, Anand A, Kaur M, Kumar V. 1. ACS Omega. 2018 Sep 30;3(9):12106-12113. doi: 10.1021/acsomega.8b01513. Epub 2018 Sep 27. PMID: 30320289; PMCID: PMC6175498.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13016 entries